
Bodal Chemicals Q4 FY23 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 3
Margin
Category 1
Fundraise
N/A
Order
N/A
Capex
Yes
2 of 3 growth signals are positive.
Full analysisRevenue guidance
Category 3- FY23 saw a revenue of ₹1,586 crore with a 23.5% degrowth due to subdued dye intermediates and dye stuff performance.
- For FY24, management expects better performance than FY23 in dye stuff and dye intermediates, though reaching past peak volumes (~18,000-20,000 MT) may be difficult due to structural demand issues.
- Chlor-Alkali business expected to improve with ongoing technology upgrades and increased utilization, targeting ~80-95% capacity.
- Benzene Derivatives Greenfield project (63,000 MT capacity) slated to start trial runs by September 2023, aiming for ₹300-400 crore turnover and ~15% EBITDA contribution, driving margin expansion.
- Overall margin expected to improve from current ~8-9% to around 11-12% in the next 1-2 years combining gains from Chlor-Alkali, Benzene Derivatives, and improved dye intermediate demand.
- Export contribution remains significant at 69% of revenue, indicating global growth focus.
See what Bodal Chemicals management said on margin guidance — free account, 30 seconds.
Fundraise plans
- As of March 2023, Bodal Chemicals Limited's total debt stood at ₹755 crore.
- The company plans to add about ₹200 crore more debt during FY24.
- Simultaneously, some repayment will start from the current year.
- Net increase in debt is expected to be around ₹150 crore.
- By the end of next fiscal year (FY24), total debt is projected to be in the range of ₹900 to ₹950 crore, including working capital.
- The resulting debt-to-equity ratio will be around 0.8, considered decent for the company size.
- There is no mention of any new equity fundraising in the transcript.
See what Bodal Chemicals management said on order book — free account, 30 seconds.
Capex plans
Yes- Bodal Chemicals is undertaking a Greenfield Benzene Derivatives project at Saykha with a total CAPEX of ₹390 crore (excluding ₹64 crore already spent on Sulphuric Acid).
- Out of the ₹390 crore, approximately ₹250 crore is planned to be spent in the current fiscal year (FY24), with project completion targeted by September or December 2023.
- The Saykha project aims to produce 63,000 metric tons per annum of Benzene Derivatives, targeting pharma and agrochemical markets.
- The Sulphuric Acid project at the Saykha Greenfield site, currently on hold, will be restarted once the site stabilizes.
- Additional forward integration products (like MPDSA and others) in the Benzene Derivatives segment are deferred to a second phase due to increased costs and market uncertainties but have environmental clearance and are ready for execution in the future.
Track Bodal Chemicals — get its next earnings analysis in your feed
How does Bodal Chemicals rank vs peers in Chemicals & Petrochemicals?
Pro featureHow does Bodal Chemicals rank in Chemicals & Petrochemicals?
Compare Bodal Chemicals against every Chemicals & Petrochemicals company (Q4 FY23) on revenue, margins and earnings-call signals.
Continue your research
What Bodal Chemicals's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Seya Industries (Q2 FY27)
Revenue from Operations (Net) for the quarter ended September 30, 2026: ₹0 lakhs (no sales reported). Key results statement takeaways from Seya Industries Ltd's
- DCM Shriram Fine Chemicals (Q2 FY27)
9,622.39 lakhs for the quarter ended September 30, 2025, indicating a year-on-year decrease of approximately 7.8%. Key results statement takeaways from DCM Shri
- Dhariwalcorp (Q2 FY27)
For the half year ended September 30, 2026, consolidated revenue from operations is ₹23,640.36 lakhs, up from ₹17,767.97 lakhs in the previous comparable…
- Agastya Energy (Q2 FY27)
For the quarter ended 30th September 2026, the consolidated revenue from operations was ₹625.15 lakhs, down from ₹4410.2 lakhs in the same quarter last year…